Medscape is available in 5 Language Editions – Choose your Edition here.


Enterovesical Fistula Treatment & Management

  • Author: Joseph Basler, MD, PhD; Chief Editor: Bradley Fields Schwartz, DO, FACS  more...
Updated: Jan 21, 2015

Medical Therapy

Nonsurgical treatment of colovesical fistulae may be a viable option in patients who cannot tolerate general anesthesia or in selected patients who can be maintained on prolonged antibacterial therapy for symptomatic relief.

Colovesical fistulae in patients with diverticulitis who are deemed to be a surgical risk have been managed conservatively. In highly select patients, nonoperative therapy has been reported as a viable treatment option. Six patients observed for 3-14 years encountered little inconvenience and were without significant complications while on intermittent antibacterial therapy alone.[53] In another study, six patients who declined surgical intervention were monitored and were found to exhibit no significant changes in renal function, and urosepticemia was not documented.[54]

If the fistula closes spontaneously, which occurs in as many as 50% of patients with diverticulitis, requirements for resection depend on the nature of the underlying colonic disease. Some patients tolerate a colovesical fistula so well that surgery is deferred indefinitely. However, although some small studies have suggested conservative management as a reasonable option, no randomized controlled trials have supported conservative management, and careful selection with close follow-up is stressed.

For enterovesical fistulae due to Crohn disease, medical therapy is the first choice.[55] Zhang et al reported that 13 of 37 patients with Crohn disease achieved long-term remission of enterovesical fistulae over a mean of 4.7 years through treatment with antibiotics, azathioprine, steroids, and/or infliximab. Significant risk factors for surgery included sigmoid-originated fistulae and concurrent Crohn disease complications such as small bowel obstruction, abscess formation, enterocutaneous fistula, enteroenteric fistula, and persistent ureteral obstruction or urinary tract infection.[56]

Patients with advanced carcinoma may be treated with catheter drainage of the bladder alone or supravesical percutaneous diversion.


Surgical Therapy

Open surgery

Colovesical fistulae can almost always be treated with resection of the involved segment of colon and primary reanastomosis. Fistulae due to inflammation are generally managed with resection of the primarily affected diseased segment of intestine, with repair of the bladder only when large visible defects are present. The bladder usually heals uneventfully with temporary urethral catheter drainage. Suprapubic tube diversion is an option but is not necessary.[57]

Historically, staged procedures were used to treat colovesical fistula. Staged repairs may be more judicious in patients with large intervening pelvic abscesses or in those with advanced malignancy or radiation changes. Most cases do not involve abscesses. If an abscess is present, spontaneous drainage through the fistula into the bladder may alleviate the immediate need for drainage if the bladder is emptying under low pressure. Further operations may be delayed pending culture results and after adequate antibiotic therapy has reduced the inflammation. A one-stage operation is recommended for patients in good general health who have a well-organized fistula and no systemic infection.[58]

A diverting colostomy, with or without urinary diversion, may be used as a long-term solution for palliation or severe radiation damage in cases of advanced cancer.

Endoscopic treatment

A review of the literature reveals one reported case of a colovesical fistula treated with transurethral resection with no evidence of recurrence in more than 2 years of follow-up.[59] With the development and advancements of hemostatic sealants, endoscopic injection of these materials is possible as a minimally invasive treatment. One concern would be the presence of foreign material in direct contact with the urine possibly acting as a nidus for stone formation. Few clinical trails have studied the application of these sealants, and this author does not recommend their use from an endoscopic approach.

Laparoscopic treatment [60]

Several reports suggest that laparoscopic resection and reanastomosis of the offending bowel segment is possible as a minimally invasive treatment.[61, 62, 63, 64] However, an abdominal incision is still required for removal of the affected intestinal segment intact for pathological assessment to rule out cancer.


Preoperative Details

The usual preoperative medical evaluation and staging (in the case of suspected or diagnosed cancer) should be performed. In addition, a preoperative mechanical and antibiotic bowel preparation is performed. At this author's institution, this includes an oral lavage with polyethylene glycol & electrolytes (GoLYTELY or its equivalent) and oral neomycin and erythromycin base. A second-generation cephalosporin is generally administered intravenously for antibiotic prophylaxis. Other variations of this bowel preparation, such as colonic irrigation with a povidone iodine (Betadine) solution, have also been used successfully. Surgeon preference dictateswhich is used. The goal is to clear as much fecal content and as many bacteria as possible before resection to allow uncomplicated healing after successful surgery.


Intraoperative Details

The colon is mobilized proximal and distal to the fistula. Pinching the colon off the bladder with blunt dissection may be possible, but this usually requires a careful and tedious sharp dissection.[51]

Inflammatory fistulae

Diverticulitis is generally managed with blunt dissection of the colon from the bladder, resection of the colon, and primary anastomosis. Often, when the colon is freed from the bladder, the bladder does not contain an actual opening. Many of these fistulous tracts are tiny, and, if the opening into the bladder is not apparent, it can be demonstrated by distending the bladder via a catheter with fluid that contains methylene blue. A large visible opening can be closed in two layers with interrupted absorbable sutures. Smaller lesions can be left alone.[3]

Fibrin sealant closure of a contaminated fistula has been described, with no evidence of fistula recurrence at 4 years.[65] The diseased bowel is resected, and a primary anastomosis is usually created. If suitable omentum is available, it may be interposed with tacking sutures between the bladder and bowel. Extensive inflammatory involvement of the bladder wall, once thought to require partial bladder resection, does not necessarily require removal of any part of the bladder. Excision of involved bladder tissue is necessary only for carcinoma.[3]

Carcinoma-related fistulae

To avoid tumor spillage, a circumscribing incision around the tumor mass and through the bladder wall is made. Frozen sections of the margins are sent for histologic analysis. Further resection is undertaken as indicated, and, if frozen section analysis results eventually return as negative, a multilayered closure and omental interposition are performed. This may help reduce postoperative complications and the risk of recurrence.

Radiation-induced fistulae

Surgery to manage radiation-induced fistulae can be difficult. In severe cases, the colorectal and adjacent organs are matted together with no natural planes, making mobilization and resection hazardous. In this situation, diverting proximal colostomy or ileostomy is advisable. In milder cases in which resection can be safely performed, a descending anal anastomosis, with or without a colonic J pouch, can be performed.[49]

The urinary system can be left intact with catheter drainage, although healing in this situation is slow and may require longer periods of catheterization. Typically, surgical separation of the genitourinary and gastrointestinal systems is required, and staged operations are more commonly performed because of the poor quality of tissues. When healing is not expected, a transverse colon conduit is often successful at restoring quality of life. Ileal and sigmoid conduits are less favorable because they have often been in the field of radiation.[23]


Most colovesical fistulae enter the bladder well away from the trigone. When fistulae enter the bladder close to the trigone, avoid periureteral dissection to prevent devascularization. If identification is difficult, ureters can be stented intraoperatively or observed either endoscopically or through the vesicostomy after intravenous injection of indigo carmine or methylene blue.


Surgical management of the bladder varies. The technique of bladder repair (ie, excision versus oversewing) is not critical, and small defects do not require any particular repair. As long as adequate bladder drainage is provided, variations in bladder management are unlikely to affect the patient outcome. When available, omentum should be applied to the serosal surface . This may be particular beneficial in the setting of acute traumatic injury to both the bladder and rectum to aid in healing and may prevent future fistula formation.[25] To date, no studies have demonstrated that the choice of absorbable suture, the number of layers of closure, or the type of postoperative bladder drainage significantly affects outcomes.


Postoperative Details

A nasogastric tube can be left in place or the patient can continue on nothing by mouth (NPO) status until bowel function returns, depending on surgeon preference. The use of rectal stimulatory suppositories (for high nonrectal fistulae) may hasten the return of bowel function. Concomitant treatment with parenteral or low-residue enteral feeding may be appropriate. Treatment with steroids is continued in patients with Crohn disease, but slower healing of the bladder should be anticipated. Bladder drainage is continued, taking care to ensure low-pressure unobstructed urine flow.



After repair of fistulae caused by benign disease, the urinary catheter is left in place for 5-7 days or longer depending on the level of inflammation and size of the repair. The patient remains on appropriate antibiotics (ie, based on preoperative culture findings and sensitivity). At the next observation, a repeat urine culture with sensitivity is obtained. The author’s preference is to perform a gravity cystography with postdrainage films to confirm healing before catheter removal. Antibiotics are continued for 24-48 hours after catheter removal until the culture results are documented as negative.

Thereafter, the primary enteric process is treated as indicated, and the patient is periodically observed with urinalysis and cultures as indicated. The patient is usually aware of the symptoms of recurrence should be encouraged to return early upon any symptoms of infection, pneumaturia, or fecaluria.

If cancer resection is performed, observational colonoscopy and CT scanning are obtained as indicated based on tumor histology findings and stage. Periodic cystoscopy may also be indicated because of the possibility of local recurrence in the detrusor muscle. Cystoscopy is especially important if the margin status of the tumor is questionable.

Certainly, any hematuria in the postoperative period should be carefully evaluated with upper tract imaging and cystoscopy.



In a 1988 study, Woods et al reported a 3.5% operative mortality rate and a complication rate of 27%.[41] Fistula recurrences have been reported in 4%-5% of patients. Most other studies have not reported such high operative mortality rates, except in the cases of severely ill patients with other significant medical problems.

Short-term complications include the usual potential problems after general surgery (eg, fever, atelectasis, slow return of bowel function, catheter-related UTI, deep vein thrombosis [DVT], wound breakdown and infection). These complications are largely preventable with incentive spirometry, early ambulation, a thromboembolic hose or anticoagulation in susceptible patients, and appropriate wound-closure techniques.

Long-term complications include persistent bladder leak (usually observed after radiotherapy for carcinoma), recurrence of a fistula (also more likely after radiotherapy), pelvic/abdominal abscess (from a leaking anastomosis), cutaneous fistulization (also from a leaking anastomosis), and bowel obstruction (from adhesions or recurrent diverticulitis).

Consider recurrent cancer in the abdomen or previously involved bladder wall when patients return with signs of bowel obstruction, new hematuria, or irritative voiding. Repeat CT scanning, serum carcinoembryonic antigen (CEA) measurement, urine culture and cytology, and cystoscopy are indicated in these settings.


Outcome and Prognosis

In a retrospective record review of 76 patients diagnosed with enterovesical fistula over a 12-year period, the complication rate in those treated with single-stage repair was not statistically different from that in patients who underwent multistage repair.[66]

In general, the overall outcome and prognosis are excellent in patients with non–radiation-induced or cancer-induced fistulae. Such patients usually respond well to resection of the diseased colon and have no significant urinary sequelae.

The prognosis in patients with colon carcinoma and fistulization is less favorable because the involvement of the bladder usually heralds a more aggressive tumor that often is metastatic at the time of detection.

Radiation-induced fistulae are more likely to recur, but the long-term patient prognosis may be better if the malignancy for which the radiation was administered has been controlled.


Future and Controversies

Future treatment of typical enterovesical fistulae may focus on development and refinement of minimally invasive surgical techniques, such as laparoscopic and robotic, to shorten recovery time and to potentially decrease hospital stay. The benefit and complications of preoperative ureteral stenting for intraoperative identification of the ureter may become a particular area of interest for clinical study. As of the latest review of this article, there is little clinical data to demonstrate the benefit of ureteral stents in preventing ureteral injury.

New modalities in neoadjuvant chemotherapy may allow further bladder preservation strategies. Trends in radiation oncology that permit minimization of collateral organ damage (eg, conformal external beam radiotherapy) and the use of tumor-specific radiosensitizing agents may be highly useful in preventing radiation-induced fistulae.

Improved surgical techniques, including laparoscopic procedures that greatly enhance visualization of the operative field, hold promise for fewer fistula-related complications of gynecologic and urologic procedures.

Advancements in molecular biology and the development of medications to manipulate inflammatory mediators may eventually produce more specifically targeted therapies to decrease the risk of fistula formation in inflammatory conditions, particularly Crohn disease.

Given the low incidence of colovesical fistula, the development of and recruitment for prospective randomized studies is difficult.

Contributor Information and Disclosures

Joseph Basler, MD, PhD Thomas P Ball Residency Education Professor, Urology Residency Program Director, Department of Urology, University of Texas Health Science Center at San Antonio; Chief, Section of Urology, Audie Murphy Veterans Affairs Hospital

Joseph Basler, MD, PhD is a member of the following medical societies: American Urological Association, Society of University Urologists, SWOG, Texas Medical Association, Society for Basic Urologic Research, Society of Urologic Oncology

Disclosure: Nothing to disclose.


Eminajulo Adekoya, MD Resident Physician, Department of Urology, University of Texas Health Science Center at San Antonio School of Medicine

Eminajulo Adekoya, MD is a member of the following medical societies: American Medical Association, American Urological Association

Disclosure: Nothing to disclose.

Specialty Editor Board

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Chief Editor

Bradley Fields Schwartz, DO, FACS Professor of Urology, Director, Center for Laparoscopy and Endourology, Department of Surgery, Southern Illinois University School of Medicine

Bradley Fields Schwartz, DO, FACS is a member of the following medical societies: American College of Surgeons, Society of Laparoendoscopic Surgeons, Society of University Urologists, Association of Military Osteopathic Physicians and Surgeons, American Urological Association, Endourological Society

Disclosure: Nothing to disclose.

Additional Contributors

Erik T Goluboff, MD Professor, Department of Urology, College of Physicians and Surgeons, Columbia University College of Physicians and Surgeons; Director of Urology, Allen Pavilion, New York Presbyterian Hospital

Erik T Goluboff, MD is a member of the following medical societies: Alpha Omega Alpha, American Medical Association, American Urological Association, Medical Society of the State of New York, New York Academy of Medicine, Phi Beta Kappa, Society for Basic Urologic Research

Disclosure: Nothing to disclose.


Christopher H Cantrill, MD Resident Physician, Department of Urology, University of Texas Health Sciences Center at San Antonio

Christopher H Cantrill, MD is a member of the following medical societies: American Association of Clinical Urologists, American Urological Association, and Endourological Society

Disclosure: Nothing to disclose.

Ann S Fenton, MD, MPH Chief, Urology Flight Surgical Services/SGOSU, 1st Fighter Wing Hospital, Langley Air Force Base; Consulting Staff, Department of Urology, Naval Medical Center Portsmouth; Assistant Professor, Eastern Virginia Medical School

Ann S Fenton, MD, MPH is a member of the following medical societies: American Urological Association

Disclosure: Nothing to disclose.

Angela Kamerer Schang, MD Attending Urologist, McKay Urology

Angela Kamerer Schang, MD is a member of the following medical societies: American Medical Association and American Urological Association

Disclosure: Nothing to disclose.

  1. Scozzari G, Arezzo A, Morino M. Enterovesical fistulas: diagnosis and management. Tech Coloproctol. 2010 Dec. 14(4):293-300. [Medline].

  2. Cripps WH. The passage of air and faeces per urethra. Lancet. 1888. 2:619.

  3. Garcea G, Majid I, Sutton CD, Pattenden CJ, Thomas WM. Diagnosis and management of colovesical fistulae; six-year experience of 90 consecutive cases. Colorectal Dis. 2006 May. 8(4):347-52. [Medline].

  4. Karamchandani MC, West CF Jr. Vesicoenteric fistulas. Am J Surg. 1984 May. 147(5):681-3. [Medline].

  5. Balsara KP, Dubash C. Complicated sigmoid diverticulosis. Indian J Gastroenterol. 1998 Apr. 17(2):46-7. [Medline].

  6. Corman ML. Colovesical fistula complicating diverticulitis in brothers. Dis Colon Rectum. 1999 Nov. 42(11):1511. [Medline].

  7. Charúa-Guindic L, Jiménez-Bobadilla B, Reveles-González A, Avendaño-Espinosa O, Charúa-Levy E. [Incidence, diagnosis and treatment of colovesical fistula]. Cir Cir. 2007 Sep-Oct. 75(5):343-9. [Medline].

  8. Dearden C, Humphreys WG. Meckel's diverticulum: a vesico-diverticular fistula. Ulster Med J. 1983. 52(1):73-4. [Medline].

  9. Kuntze JR, Herman MH, Evans SG. Genitourinary coccidioidomycosis. J Urol. 1988 Aug. 140(2):370-4. [Medline].

  10. Piper JV, Stoner BA, Mitra SK, Talerman A. Ileo-vesical fistula associated with pelvic actinomycosis. Br J Clin Pract. 1969 Aug. 23(8):341-3. [Medline].

  11. Cakmak MA, Aaronson IA. Appendicovesical fistula in a girl with cystic fibrosis. J Pediatr Surg. 1997 Dec. 32(12):1793-4. [Medline].

  12. Cockell A, McQuillan T, Doyle TN, Reid DJ. Colovesical fistula caused by appendicitis. Br J Clin Pract. 1990 Dec. 44(12):682-3. [Medline].

  13. Yamamoto H, Yoshida M, Sera Y, et al. Laparoscopic diagnosis of appendicovesical fistula in a pediatric patient. Surg Laparosc Endosc. 1997 Jun. 7(3):266-7. [Medline].

  14. Athanassopoulos A, Speakman MJ. Appendicovesical fistula. Int Urol Nephrol. 1995. 27(6):705-8. [Medline].

  15. Carter D, Choi HY, Telford G, Otterson M, Chitapalli K, Pintar K. Lymphadenopathy and entero-vesical fistula in Fabry's disease. Am J Clin Pathol. 1988 Dec. 90(6):726-31. [Medline].

  16. Téllez Martinez-Fornés M, Fernandez A, Burgos F, et al. Colovesical fistula secondary to vesical gangrene in a diabetic patient. J Urol. 1991 Oct. 146(4):1115-7. [Medline].

  17. Abbas F, Memon A. Colovesical fistula: an unusual complication of prostatomegaly. J Urol. 1994 Aug. 152(2 Pt 1):479-81. [Medline].

  18. Pontari MA, McMillen MA, Garvey RH, Ballantyne GH. Diagnosis and treatment of enterovesical fistulae. Am Surg. 1992 Apr. 58(4):258-63. [Medline].

  19. Dawam D, Patel S, Kouriefs C, Masood S, Khan O, Sheriff MK. A "urological" enterovesical fistula. J Urol. 2004 Sep. 172(3):943-4. [Medline].

  20. Paul AB, Thomas JS. Enterovesical fistula caused by small bowel lymphoma. Br J Urol. 1993 Jan. 71(1):101-2. [Medline].

  21. Miller B, Morris M, Gershenson DM, et al. Intestinal fistulae formation following pelvic exenteration: a review of the University of Texas M. D. Anderson Cancer Center experience, 1957-1990. Gynecol Oncol. 1995 Feb. 56(2):207-10. [Medline].

  22. Gray MR, Curtis JM, Elkington JS. Colovesical fistula after laparoscopic inguinal hernia repair. Br J Surg. 1994 Aug. 81(8):1213-4. [Medline].

  23. Levenback C, Gershenson DM, McGehee R, et al. Enterovesical fistula following radiotherapy for gynecologic cancer. Gynecol Oncol. 1994 Mar. 52(3):296-300. [Medline].

  24. Ansari MS, Nabi G, Singh I, et al. Colovesical fistula an unusual complication of cytotoxic therapy in a case of non-Hodgkin's lymphoma. Int Urol Nephrol. 2001. 33(2):373-4. [Medline].

  25. Crispen PL, Kansas BT, Pieri PG, Fisher C, Gaughan JP, Pathak AS, et al. Immediate postoperative complications of combined penetrating rectal and bladder injuries. J Trauma. 2007 Feb. 62(2):325-9. [Medline].

  26. Nelson AM, Frank HD, Taubin HL. Colovesical fistula secondary to foreign-body perforation of the sigmoid colon. Dis Colon Rectum. 1979 Nov-Dec. 22(8):559-60. [Medline].

  27. Potter D, Smith D, Shorthouse AJ. Colovesical fistula following ingestion of a foreign body. Br J Urol. 1998 Mar. 81(3):499-500. [Medline].

  28. Andrews NJ, Hall CN, Taylor TV. Colovesical fistula caused by a chicken bone. Br J Urol. 1988 Dec. 62(6):617. [Medline].

  29. Daoud F, Awwad ZM, Masad J. Colovesical fistula due to a lost gallstone following laparoscopic cholecystectomy: report of a case. Surg Today. 2001. 31(3):255-7. [Medline].

  30. Khan MS, Bryson C, O'Brien A, Mackle EJ. Colovesical fistula caused by chronic chicken bone perforation. Ir J Med Sci. 1996 Jan-Mar. 165(1):51-2. [Medline].

  31. Driver CP, Anderson DN, Findlay K, et al. Vesico-colic fistulae in the Grampian region: presentation, assessment, management and outcome. J R Coll Surg Edinb. 1997 Jun. 42(3):182-5. [Medline].

  32. Krco MJ, Jacobs SC, Malangoni MA, Lawson RK. Colovesical fistulas. Urology. 1984 Apr. 23(4):340-2. [Medline].

  33. Corman ML. Colovesical Fistula. Colon and Rectal Surgery. Philadelphia, Pa: JB Lippincott; 1984. 505.

  34. Golabek T, Szymanska A, Szopinski T, Bukowczan J, Furmanek M, Powroznik J, et al. Enterovesical fistulae: aetiology, imaging, and management. Gastroenterol Res Pract. 2013. 2013:617967. [Medline]. [Full Text].

  35. Shinojima T, Nakajima F, Koizumi J. Efficacy of 3-D computed tomographic reconstruction in evaluating anatomical relationships of colovesical fistula. Int J Urol. 2002 Apr. 9(4):230-2. [Medline].

  36. Jarrett TW, Vaughan ED. Accuracy of computerized tomography in the diagnosis of colovesical fistula secondary to diverticular disease. J Urol. 1995 Jan. 153(1):44-6. [Medline].

  37. Labs JD, Sarr MG, Fishman EK, et al. Complications of acute diverticulitis of the colon: improved early diagnosis with computerized tomography. Am J Surg. 1988 Feb. 155(2):331-6. [Medline].

  38. Narumi Y, Sato T, Kuriyama K, Fujita M, Mitani T, Kameyama M. Computed tomographic diagnosis of enterovesical fistulae: barium evacuation method. Gastrointest Radiol. 1988 Jul. 13(3):233-6. [Medline].

  39. Caoili EM, Cohan RH, Korobkin M, et al. Urinary tract abnormalities: initial experience with multi-detector row CT urography. Radiology. 2002 Feb. 222(2):353-60. [Medline].

  40. Ing A, Lienert A, Frizelle F. Medical image. CT colonography for colovesical fistula. N Z Med J. 2008 Aug 8. 121(1279):105-8. [Medline].

  41. Woods RJ, Lavery IC, Fazio VW, et al. Internal fistulas in diverticular disease. Dis Colon Rectum. 1988 Aug. 31(8):591-6. [Medline].

  42. Amendola MA, Agha FP, Dent TL, et al. Detection of occult colovesical fistula by the Bourne test. AJR Am J Roentgenol. 1984 Apr. 142(4):715-8. [Medline].

  43. Kaisary AV, Grant RW. "Beehive on the bladder": an indication of colovesical disease. Br J Urol. 1984 Feb. 56(1):35-7. [Medline].

  44. Long MA, Boultbee JE. Case report: the transabdominal ultrasound appearances of a colovesical fistula. Br J Radiol. 1993 May. 66(785):465-7. [Medline].

  45. Chen SS, Chou YH, Tiu CM, Chang T. Sonographic features of colovesical fistula. J Clin Ultrasound. 1990 Sep. 18(7):589-91. [Medline].

  46. Haggett PJ, Moore NR, Shearman JD, Travis SP, Jewell DP, Mortensen NJ. Pelvic and perineal complications of Crohn's disease: assessment using magnetic resonance imaging. Gut. 1995 Mar. 36(3):407-10. [Medline].

  47. Koelbel G, Schmiedl U, Majer MC, et al. Diagnosis of fistulae and sinus tracts in patients with Crohn disease: value of MR imaging. AJR Am J Roentgenol. 1989 May. 152(5):999-1003. [Medline].

  48. Ravichandran S, Ahmed HU, Matanhelia SS, Dobson M. Is there a role for magnetic resonance imaging in diagnosing colovesical fistulas?. Urology. 2008 Oct. 72(4):832-7. [Medline].

  49. Lavery IC. Colonic fistulas. Surg Clin North Am. 1996 Oct. 76(5):1183-90. [Medline].

  50. Kwon EO, Armenakas NA, Scharf SC, Panagopoulos G, Fracchia JA. The poppy seed test for colovesical fistula: big bang, little bucks!. J Urol. 2008 Apr. 179(4):1425-7. [Medline].

  51. Rames RA, Bissada N, Adams DB. Extent of bladder and ureteric involvement and urologic management in patients with enterovesical fistulas. Urology. 1991 Dec. 38(6):523-5. [Medline].

  52. Najjar SF, Jamal MK, Savas JF, Miller TA. The spectrum of colovesical fistula and diagnostic paradigm. Am J Surg. 2004 Nov. 188(5):617-21. [Medline].

  53. Amin M, Nallinger R, Polk HC Jr. Conservative treatment of selected patients with colovesical fistula due to diverticulitis. Surg Gynecol Obstet. 1984 Nov. 159(5):442-4. [Medline].

  54. Solkar MH, Forshaw MJ, Sankararajah D, Stewart M, Parker MC. Colovesical fistula--is a surgical approach always justified?. Colorectal Dis. 2005 Sep. 7(5):467-71. [Medline].

  55. Fiocchi C. Closing fistulas in Crohn's disease--should the accent be on maintenance or safety?. N Engl J Med. 2004 Feb 26. 350(9):934-6. [Medline].

  56. Zhang W, Zhu W, Li Y, Zuo L, Wang H, Li N, et al. The respective role of medical and surgical therapy for enterovesical fistula in Crohn's disease. J Clin Gastroenterol. 2014 Sep. 48(8):708-11. [Medline].

  57. Ferguson GG, Lee EW, Hunt SR, Ridley CH, Brandes SB. Management of the bladder during surgical treatment of enterovesical fistulas from benign bowel disease. J Am Coll Surg. 2008 Oct. 207(4):569-72. [Medline].

  58. Kirsh GM, Hampel N, Shuck JM, Resnick MI. Diagnosis and management of vesicoenteric fistulas. Surg Gynecol Obstet. 1991 Aug. 173(2):91-7. [Medline].

  59. Van Thillo EL, Delaere KP. Endoscopic treatment of colovesical fistula. An endoscopical approach. Acta Urol Belg. 1992. 60(2):151-2. [Medline].

  60. Puente I, Sosa JL, Desai U, et al. Laparoscopic treatment of colovesical fistulas: technique and report of two cases. Surg Laparosc Endosc. 1994 Apr. 4(2):157-60. [Medline].

  61. Joo JS, Agachan F, Wexner SD. Laparoscopic surgery for lower gastrointestinal fistulas. Surg Endosc. 1997 Feb. 11(2):116-8. [Medline].

  62. Petropoulos P, Nassiopoulos K, Chanson C. [Laparoscopic therapy of diverticulitis]. Zentralbl Chir. 1998. 123(12):1390-3. [Medline].

  63. Perniceni T, Burdy G, Gayet B, et al. [Results of elective segmental colectomy done with laparoscopy for complicated diverticulosis]. Gastroenterol Clin Biol. 2000 Feb. 24(2):189-92. [Medline].

  64. Siriser F. Laparoscopic-assisted colectomy for diverticular sigmoiditis. A single-surgeon prospective study of 65 patients. Surg Endosc. 1999 Aug. 13(8):811-3. [Medline].

  65. Moesgaard F, Hoffmann S, Nielsen R. Successful fibrin seal closure of a contaminated fistula. Case report. Acta Chir Scand. 1989 Aug. 155(8):427-8. [Medline].

  66. McBeath RB, Schiff M, Allen V, et al. A 12-year experience with enterovesical fistulas. Urology. 1994 Nov. 44(5):661-5. [Medline].

CT scan showing the adherence of the sigmoid colon to the lateral edge of the bladder.
A lower cut of the CT scan from the related image. Note the sigmoid colon in direct proximity to the fistula and the air in the bladder.
A CT scan one cut further inferiorly from the related images, showing the typical air pattern in the bladder and more obvious inflammatory changes at the site of the vesicoenteric fistula.
An endoscopic view of colovesical fistula (upper right). Note the prominent edema and erythema characteristic of the fistula (ie, herald patch). Occasionally, a whitish discharge with the consistency of toothpaste can be observed emanating from the orifice. The presentation of a vesicoenteric fistula includes the presence of air, fecal material, and polymicrobial recurrent urinary tract infection.
A white mucinous exudate is observed emanating from the site of a colovesical fistula in a patient with both a sigmoid diverticular abscess and colon cancer.
After a bladder wash-out, the fistula appears as a raised, edematous, sessile lesion in the bladder. The air bubble is observed at the top of the photo, and some remnant mucus threads are adherent at the bottom.
The edema surrounding the fistula often extends for a considerable distance around the bladder wall. A cobblestone appearance is typical when chronic inflammation is present.
Colovesical fistula identified on CT scan in a patient with diverticular disease and fecaluria. Arrow – fistula, B – bladder, C – sigmoid colon with diverticula.
Colovesical fistula visualization on sagittal MRI. Arrow – fistula, B – bladder, C – sigmoid colon.
Operative view from superior and anterior showing the bladder (B) and colon (C) with area of erythema at the site surrounding the fistula.
Cystoscopic view of an anastomotic urethrorectal fistula that developed after radical prostatectomy. The patient remains asymptomatic with occasional pneumaturia. This is an uncommon complication of radical prostatectomy.
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.